These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12848731)

  • 1. Remote abscess formation during interferon-alpha therapy for viral hepatitis.
    Gogos CA; Starakis JK; Bassaris HP; Skoutelis AT
    Clin Microbiol Infect; 2003 Jun; 9(6):540-2. PubMed ID: 12848731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
    Jablonowski H
    Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
    Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
    J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viral hepatitis B/C and HIV. Therapy of double infections].
    Mauss S
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-associated retinopathy.
    Chambers RB; Downie A; Foote B; Davidorf FH
    J Am Osteopath Assoc; 1997 Jan; 97(1):43-5. PubMed ID: 9029879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.
    Haria M; Benfield P
    Drugs; 1995 Nov; 50(5):873-96. PubMed ID: 8586031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection.
    Endo M; Ohi H; Fujita T; Ohsawa I; Kanmatsuse K; Yamaguchi Y
    Am J Nephrol; 1998; 18(5):439-43. PubMed ID: 9730572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.
    Wu JY; Shadbolt B; Teoh N; Blunn A; To C; Rodriguez-Morales I; Chitturi S; Kaye G; Rodrigo K; Farrell G
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1258-64. PubMed ID: 24955454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of HBV/HCV coinfection: releasing the enemy within.
    Gordon SC; Sherman KE
    Gastroenterology; 2009 Feb; 136(2):393-6. PubMed ID: 19105960
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Side effects of interferon-alpha].
    Vial T; Bailly F; Descotes J; Trepo C
    Gastroenterol Clin Biol; 1996; 20(5):462-89. PubMed ID: 8761145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferon therapy for hepatitis B and C].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.
    Braga-Basaria M; Basaria S
    J Endocrinol Invest; 2003 Mar; 26(3):261-4. PubMed ID: 12809178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.
    Kogure T; Ueno Y; Fukushima K; Nagasaki F; Inoue J; Kakazu E; Matsuda Y; Kido O; Nakagome Y; Kimura O; Obara N; Wakui Y; Iwasaki T; Shimosegawa T
    World J Gastroenterol; 2007 Aug; 13(32):4394-7. PubMed ID: 17708618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
    Misery L
    J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
    Potthoff A; Berg T; Wedemeyer H;
    Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Jeng YM; Chen DS
    Hepatology; 2003 Mar; 37(3):568-76. PubMed ID: 12601355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.